News | May 11, 2024
Ami Organics posts Q4 FY24 consolidated profit at Rs. 25.14 Cr
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.8.29 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.615.82 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
The company has posted net loss of Rs. 105.07 crores for the Financial Year ended March 31, 2024
Subscribe To Our Newsletter & Stay Updated
